GABA and Beta-cell Regeneration
Sponsored by Ministry of Health and Population, Egypt
About this trial
Last updated 5 years ago
Study ID
icel
Status
Completed
Type
Observational [Patient Registry]
Placebo
No
Accepting
18 to 25 Years
All
Trial Timing
Ended 5 years ago
What is this trial about?
GABA(gamma-Aminobutyric acid) may be used for decreasing anti-gad antibodies and leads
beta-cell regeneration.
What are the participation requirements?
Inclusion Criteria
- type 1 diabetes patients age from 18 to 25 years on basal bolus insulin
Exclusion Criteria
thyroid problems liver disease kidney disease